Business Wire

Team Develops Plan to Globally Crowdsource Breakthrough Innovations to End Alzheimer’s

Jaa

Frustrated by the absence of public urgency and funding to stop Alzheimer’s—and the slow pace of science—a world-class team of scientists and advocates are joining forces to globally crowdsource a new 21st century approach to leapfrog scientific progress and overcome many of the obstacles to stopping this horrific disease.

The call to discover breakthrough new technologies for brain health is intended to activate interest from a broad spectrum of expert and lay innovators worldwide—from fields as wide-ranging as artificial intelligence, bio-technology, precision pharmaceuticals, physics, video games and brain hacking—to focus their talents and ingenuity on detecting the earliest moments of Alzheimer’s.

“With unprecedented global aging, unless Alzheimer’s disease is stopped—and stopped soon—it will become the health, social and financial sinkhole of the 21st century,” said Ken Dychtwald, PhD, Founder and CEO of Age Wave, and a founding member of the Alzheimer’s Breakthrough team.

At the XPRIZE Visioneers Summit in early October, the Alzheimer’s Breakthrough team will present their innovative proposal—in competition with four other teams focused on other global grand challenges including clean air, zero waste mining, cybersecurity and re-imagining democracy—to a group of 300 scientists, academics, visionaries and funders who will determine which of the prize concepts are “certified to launch.”

The original idea of an Alzheimer’s Breakthrough team was conceived by psychologist/gerontologist Dychtwald and Dr. Peter H. Diamandis, Founder and Executive Chairman of the XPRIZE Foundation, in the fall of 2012. Dychtwald was captivated by XPRIZE’s bold and innovative approach to solving some of the biggest problems of our time.

According to George Vradenburg, JD, Co-Founder and Chairman of UsAgainstAlzheimer’s and a founding member of the Alzheimer’s Breakthrough team, “By employing global crowdsourcing and harnessing emerging technologies, we are hoping to unleash a new era of interventions and treatments that would have the best chance of saving lives.”

“If we prevent Alzheimer’s, we’re going to unlock vast amounts of human potential and reduce or eliminate the suffering of tens of millions of victims and their families,” said Philip Edgcumbe, PhD, a 28-year-old Canadian scientist, biomedical engineer, entrepreneur and medical student who is leading the Alzheimer’s team. “There is currently no cure for Alzheimer’s disease, which affects nearly 50 million people worldwide and is expected to triple in the coming decades due to increasing longevity and the global age wave.”

According to Lisa Genova, PhD, a Harvard trained neuroscientist and best-selling author of Still Alice, “If an XPRIZE were launched to tackle Alzheimer’s, it could change the world’s perception of this disease—from hopelessness that it will never be cured to a hopeful expectation that we will soon have a prevention, treatments or even a cure, much as we’ve seen with tuberculosis, typhoid, diphtheria, polio, certain cancers, HIV and heart disease.”

More than 100 leading neuroscientists, advocates and exponential technology experts have contributed their ideas and insights to this process. Team advisors include: Maria Shriver, activist, journalist, former first lady of California; Geoffrey Ling, MD, PhD, former Founding Director of bio-tech at DARPA; Rudi Tanzi, PhD, Professor of Neurology, Harvard University; Reisa Sperling, MD, Professor of Neurology, Harvard Medical School; Ajay Verma, MD, PhD, CMO at United Neurosciences; and Daniel Kraft, MD, Founding Executive Director Exponential Medicine, Singularity University.

Contact information

UsAgainstAlzheimer’s
Jeannette O’Connor, 202-302-3268
Joconnor@usagainstalzheimers.org
or
Age Wave
Robyn Reynolds, 510-899-4004
Rreynolds@agewave.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme tältä julkaisijalta, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

BearingPoint: How Firms Transform into Digital Superpowers22.2.2018 11:30Tiedote

Digital disruption has left Europe’s leading companies struggling to sustain growth and competitive advantage. Groundbreaking new research reveals how European companies can learn from US digital superpowers to speed up adoption of business model innovation, drive new revenues and get greater value from their core business. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180222005241/en/ Diversifying business model Portfolio (Graphic: Business Wire) Today, firms that adopt a portfolio of business models which are asset light and include network effects are perceived by investors and the market as most likely to generate future growth. They therefore have a much higher market value in comparison to companies with traditional business models. Companies who diversified their business models improved their valuation in 2016 by 65% in comparison to those who maintained a mono-business model. Furthermore, between 2011-2016 they mana

Eli Global to Acquire Lead Generation Marketplace Finanzen22.2.2018 11:00Tiedote

Eli Global LLC (“Eli”) today announced that an affiliate has entered into a definitive agreement to acquire finanzen.de AG and its subsidiaries (collectively, “Finanzen” or the “company”) from Blackfin Capital Partners (“Blackfin”) and Finanzen’s founders. Based in Berlin, Germany, Finanzen is the leading European online marketplace for retail customer leads in the finance and insurance sectors. The company connects lead generators such as online price comparison sites with lead buyers such as independent financial advisors and insurance agents. The company also acts as an online broker for certain insurance products. “Finanzen has done an impressive job creating a scalable technology platform poised to benefit from industry trends,” said George Luecke, global manager of Eli’s newly established insurance services portfolio and co-CEO of Global Bankers Insurance Group, which represents Eli’s life and annuity carrier division (“GBIG”). “We look forward to a long-term future with the comp

Ferring Pharmaceuticals and MSD Announce Completion of Largest Clinical Trial Ever Conducted in Postpartum Haemorrhage22.2.2018 09:00Tiedote

Ferring Pharmaceuticals and MSD, known as Merck & Co., Inc., Kenilworth, N.J., U.S.A., through its MSD for Mothers initiative, today announced the completion of CHAMPION (Carbetocin Haemorrhage Prevention), a global clinical trial conducted by the Human Reproduction Program (HRP) at the World Health Organization (WHO). CHAMPION is investigating whether Ferring’s proprietary and heat-stable carbetocin could offer a new solution to prevent excessive bleeding after childbirth (postpartum haemorrhage or PPH).2,3 Involving nearly 30,000 women in 10 countries, it is the largest clinical trial ever conducted in PPH.2,3 This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180221006496/en/ Each year, 14 million mothers are affected by PPH.4 As the leading direct cause of maternal mortality, 480,000 mothers died from PPH between 2003-09.1 Even when women survive, PPH can result in the need for serious medical interventions, including surgica

The Nippon Foundation: Project to Map Ocean Floor by 2030 Now Operational22.2.2018 08:00Tiedote

The Nippon Foundation Chairman Yohei Sasakawa announced at a press conference today that The Nippon Foundation – GEBCO Seabed 2030 Project is now operational. The Project will realize Mr. Sasakawa’s vision of mapping the entire ocean floor by 2030. The Nippon Foundation has pledged US$2 million annually, and is calling for additional support from the global ocean community. Mr. Sasakawa noted, “The Nippon Foundation alone cannot achieve the objectives of this ambitious project. We will need the support of diverse stakeholders, including maritime corporations and technical experts. It is crucial that the ocean community comes together to achieve this goal”. He was joined by leading ocean-mapping experts, who emphasized that understanding the bathymetry of the global ocean is imperative for improving maritime navigation, and also for enhancing our ability to predict climate change and monitor marine biodiversity and resources. A comprehensive map of the seafloor will assist global effort

Vertex Initiates First Phase 3 Study of VX-659, Tezacaftor and Ivacaftor as a Triple Combination Regimen for People with Cystic Fibrosis22.2.2018 00:01Tiedote

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it is initiating the first Phase 3 study of VX-659, tezacaftor and ivacaftor as an investigational triple combination regimen for people with cystic fibrosis (CF) who have one F508del mutation and one minimal function mutation. The study will enroll 360 patients, and the primary endpoint of the study is the mean absolute change from baseline in percent predicted forced expiratory volume in one second (ppFEV1) at week four of treatment. The study is designed to support the submission of a New Drug Application (NDA) in the U.S. using data from the 4-week primary efficacy endpoint together with safety data through 12 weeks of treatment. “Our goal is to bring the best triple combination to patients as rapidly as possible, and this first Phase 3 study of VX-659 in combination with tezacaftor and ivacaftor is a significant step toward that goal,” said Jeffrey Chodakewitz, M.D., Executive Vice President and Chief Medical

Universal Laser Systems® Expands Portfolio of Laser Material Processing Systems with the ULTRA Platform Series21.2.2018 21:00Tiedote

ULTRA platform-based laser systems are designed and ideally suited for precision laser cutting, laser ablation, and laser surface modification in manufacturing, research and development, academic research and prototyping environments. Major features of the series include rapid, high-accuracy laser beam positioning, and the flexibility to be configured with 9.3 and 10.6 µm CO2 lasers and 1.06 µm fiber lasers. All lasers are air-cooled in a range of power from 10 to 150 watts for CO2 and 40 to 50 watts for fiber lasers. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180221005364/en/ The ULTRA 9MW offers MultiWave processing of thin materials. (Photo: Business Wire) The variety of wavelengths and power ranges make the ULTRA platforms highly effective in the areas of organic material modification, including plastic films, industrial fabrics, engineering plastics, laminating adhesives, composite materials, and many others utilized

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme